Evguenia S. Svarovskaia
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, HIV Research and Treatment
Most-Cited Works
- → Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis(2014)1,121 cited
- → Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection(2015)1,110 cited
- → Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3(2014)796 cited
- → Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C(2013)754 cited
- → Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection(2017)559 cited
- → Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study(2014)330 cited
- → Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes(2018)307 cited
- → Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs(2004)267 cited
- → Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and Integration(2007)265 cited
- → Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection(2014)254 cited